Efficaccy of probiotic in the treatment of small intestinal bacterial overgrowth. Systematic review and meta-analysis
DOI:
https://doi.org/10.47892/rgp.2024.443.1692Keywords:
Blind loop syndrome, Probiotics, Irritable bowel syndrome, Treatment outcomeAbstract
Introduction: Conventional management of small intestinal bacterial overgrowth (SIBO) involves intraluminal-action antibiotics. Controversially, probiotics are used to optimize outcomes, but this therapeutic intervention is understudied. Objective: To evaluate the efficacy of probiotics in the treatment of small intestinal bacterial overgrowth. Materials and methos: A search was conducted using relevant terms guided by a documentalist in CENTRAL, MEDLINE, and EMBASE, LILACS, conference proceedings, the International Clinical Trials Registry Platform (ICTRP), and ClinicalTrials.gov, in English or Spanish, up to January 2023. The search aimed to identify studies evaluating the effectiveness of probiotics in small intestinal bacterial overgrowth. Controlled trials of probiotics compared to placebo or other interventions (antibiotics) for symptom control and normalization of hydrogen breath test in adult patients with small intestinal bacterial overgrowth were included. Two authors independently assessed and extracted data. Information on methods, participants, interventions, and outcomes (resolution of SIBO by hydrogen breath test, symptom control) was collected. When appropriate, risk ratios (OR) with 95% confidence intervals (CI) were calculated. Study quality was evaluated using the Cochrane Risk of Bias Assessment Tool. Results: A total of 18 clinical trials were found, including one case-control study, two crossover trials, and one single-arm clinical trial. Out of these, 14 clinical trials had a control group, of which 9 were randomized, collecting information from 496 patients treated with probiotics and 480 controls. Among them, 6 clinical trials compared probiotics (n=122) against placebo (n=104). Due to lack of uniformity in outcome reporting, only 3 of these studies were included in the meta-analysis, revealing a favorable effect of probiotics in resolving SIBO by hydrogen breath test (OR=0.3, 95% CI, 0.3-1.0). The studies showed high heterogeneity and a high risk of bias. Conclusions: Using the GRADE methodology, we found low-quality clinical evidence in favor of using probiotics compared to placebo for the resolution of SIBO.
Downloads
Metrics
References
Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.
Bushyhead D, Quigley EM. Small Intestinal Bacterial Overgrowth. Gastroenterol Clin North Am. 2021;50(2):463-74. doi: 10.1016/j.gtc.2021.02.008.
Ahmed JF, Padam P, Ruban A. Aetiology, diagnosis and management of small intestinal bacterial overgrowth. Frontline Gastroenterol. 2023;14(2):149-54. doi: 10.1136/flgastro-2022-102163.
Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978-90. doi: 10.3748/wjg.v16.i24.2978.
García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, Carranza-Muleiro RA, Jara LJ, Vera-Lastra O, et al. Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Dig Dis Sci. 2020;65(4):1134-43. doi: 10.1007/s10620-019-05830-0.
Scarpellini E, Lauritano EC, Lupasen A, Novi M, Gabrielli M, Nucera G, et al. Bacillus clausii treatment of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Dig Liver Dis. 2006;38 Suppl 1:S32.
Attar A, Flourié B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999;117(4):794-7. doi: 10.1016/s0016-5085(99)70336-7.
Khalighi AR, Khalighi MR, Behdani R, Jamali J, Khosravi A, Kouhestani Sh, et al. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) - A pilot study. Indian J Med Res. 2014;140(5):604-8.
Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, et al. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: A comparative evaluation. Curr Clin Pharmacol. 2013;8(2):169-72. doi: 10.2174/15748847113089990048.
Fanigliulo L, Comparato G, Aragona G, Cavallaro L, Iori V, Maino M, et al. Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed Ateneo Parm. 2006;77(2):85-9.
Bustos Fernández LM, Man F, Lasa JS. Impact of Saccharomyces boulardii CNCM I-745 on bacterial overgrowth and composition of intestinal microbiota in IBS-D patients: results of a randomized pilot study. Dig Dis. 2023;41(5):798-809. doi: 10.1159/000528954.
Kwak DS, Jun DW, Seo JG, Chung WS, Park SE, Lee KN, et al. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. Eur J Gastroenterol Hepatol. 2014;26(12):1353-9. doi: 10.1097/MEG.0000000000000214.
Ma ZF, Yusof N, Hamid N, Lawenko RM, Mohammad WMZW, Liong MT, et al. Bifidobacterium infantis M-63 improves mental health in victims with irritable bowel syndrome developed after a major flood disaster. Benef Microbes. 2019;10(2):111-20. doi: 10.3920/BM2018.0008
Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol. 2017;51(4):300-11. doi: 10.1097/MCG.0000000000000814.
Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165-78. doi: 10.14309/ajg.0000000000000501.
Rao SSC, Rehman A, Yu S, Andino NM de. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018;9(6):162. doi: 10.1038/s41424-018-0030-7.
Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53(6):1443-54. doi: 10.1007/s10620-007-0065-1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sebastian Fernando Niño, Marco Santiesteban, Gloria Muñoz Valencia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
2022 